Book on Whatsapp
9892101616
Breast Cancer Awareness Month: The Significance of Early Detection and Testing in India
Womens Health
Tue Oct 01 2024
October marks International Breast Cancer Awareness Month, a global initiative aimed at promoting education, early detection, and regular screenings for breast cancer. With breast cancer being the second most common cancer worldwide, it is crucial to emphasize the importance of early testing, particularly in India where awareness and access to screening are still growing.
Globally, 2.3 million cases of breast cancer were reported in 2022, according to the World Health Organization’s Global Cancer Observatory (GLOBOCAN). Many countries, including the US and Japan, recommend screening as early as 40 years of age. However, some nations, like Canada and Germany, begin at 50. In India, where awareness is still catching up, it is essential to encourage women to start regular screenings earlier, given that a significant number of cases are diagnosed in younger women.
The standard for breast cancer detection is mammography, which has proven to be a reliable method for identifying breast cancer in its early stages. However, for women with dense breast tissue or those too young for regular mammogram screenings, there are additional diagnostic options available. These include various in vitro diagnostic (IVD) tests, such as blood tests that identify specific biomarkers associated with breast cancer.
In particular, newer blood tests have emerged that offer an alternative for women with lower mammogram sensitivity. These tests analyze a patient’s blood sample for biomarkers linked to breast cancer, providing an easier and less invasive screening option. This is particularly useful for women under 50, as nearly 30% of global breast cancer cases occur in this age group. The simplicity and accessibility of a blood draw could encourage more women to participate in regular screenings, potentially catching cancer in its earliest stages.
Once breast cancer is diagnosed, treatment plans are increasingly being guided by genetic testing, a growing area of precision medicine. Companion diagnostics (CDx) help physicians tailor treatment based on the patient’s specific tumor characteristics. These tests identify genetic mutations, such as BRCA-1 and BRCA-2, and guide doctors in selecting targeted therapies, ensuring a more personalized and effective treatment approach.
While mammography remains the gold standard for screening, the future of breast cancer testing continues to evolve. As new tests emerge, they may complement traditional methods, offering higher sensitivity for certain populations and providing valuable insights for clinicians to personalize treatment.
Suggested Tests:
Mammogram, BRCA gene test, blood test for breast cancer markers.
Related Tests
Related Packages
Related Blogs

Womens Health
Female Infertility Profile Test for Hormonal Evaluation
Infertility is a growing concern among women across the globe, affecting not only physical health but also emotional well-being. The ability to conceive depends on a complex interplay of various hormones that regulate ovulation, menstrual cycles, and reproductive health. When there is an imbalance or disruption in these hormones, it can significantly affect fertility. A Female Infertility Profile Test for Hormonal Evaluation is a comprehensive diagnostic tool designed to identify such imbalances and guide appropriate treatment.
Understanding the Role of Hormones in Fertility
Hormones are chemical messengers that control vital reproductive functions in women. From the release of eggs during ovulation to the preparation of the uterine lining for implantation, every step depends on hormonal balance. Even a minor fluctuation can lead to irregular menstrual cycles, difficulty in conceiving, or pregnancy complications. Therefore, assessing hormonal levels is one of the first steps in infertility investigations.
What is a Female Infertility Profile Test?
The Female Infertility Profile Test is a panel of blood tests that measure the levels of essential reproductive hormones. These tests help in evaluating whether a woman is ovulating regularly, whether her ovaries are functioning well, and whether other endocrine disorders are interfering with fertility. By identifying the root cause of infertility, doctors can create a targeted treatment plan, ranging from medication to assisted reproductive techniques.
Key Hormones Evaluated in the Test
- Follicle-Stimulating Hormone (FSH): FSH is responsible for stimulating the ovaries to produce eggs. Abnormal levels may indicate poor ovarian reserve or premature ovarian failure.
- Luteinizing Hormone (LH): LH plays a critical role in triggering ovulation. An imbalance in LH levels can lead to conditions such as Polycystic Ovary Syndrome (PCOS).
- Estradiol (E2): Estradiol, a form of estrogen, helps in the development of the uterine lining. Low levels may hinder implantation, while excessively high levels may signal ovarian dysfunction.
- Progesterone: This hormone supports pregnancy by preparing the uterus for embryo implantation. Insufficient progesterone can cause recurrent miscarriages or infertility.
- Prolactin: Elevated prolactin levels may interfere with ovulation and menstrual regularity, often linked to pituitary gland issues.
- Thyroid Hormones (T3, T4, TSH): Thyroid disorders are closely associated with infertility. Both hypothyroidism and hyperthyroidism can disrupt ovulation and menstrual cycles.
- Anti-Müllerian Hormone (AMH): AMH provides an estimate of ovarian reserve, helping women understand their fertility potential.
Importance of the Test
The Female Infertility Profile Test is crucial because infertility is often multifactorial. While structural abnormalities or lifestyle factors play a role, hormonal dysfunction remains one of the most common causes. By analyzing hormonal patterns, doctors can determine whether fertility treatments like ovulation induction, in vitro fertilization (IVF), or hormone therapy will be effective.
Benefits of Early Hormonal Evaluation
Early evaluation not only saves time but also reduces emotional distress. Women who undergo this test gain clarity about their reproductive health and can make informed decisions. In addition, detecting issues like PCOS, thyroid disorders, or premature menopause at the right time allows for proper treatment, which may restore fertility.
Infertility is a sensitive issue, but modern diagnostic tools like the Female Infertility Profile Test for Hormonal Evaluation bring hope to many women. By identifying hormonal imbalances early, this test paves the way for timely interventions and increases the chances of conception. For women struggling with infertility, it is not just a medical test, it is a step toward understanding their body better and moving closer to the dream of motherhood.
At Manipal TRUtest, our comprehensive infertility profile tests are designed to provide accurate insights and compassionate care, helping women take the next step with confidence.

Womens Health
Complete Diagnostic Package for Senior Citizen Women
A woman’s health undergoes significant changes with age, particularly after the age of 60. The senior years bring wisdom, experience, and fulfilment, but they also increase the risk of chronic illnesses and age-related conditions. Regular health check-ups play a vital role in maintaining overall well-being, ensuring timely detection of diseases, and improving quality of life. A complete diagnostic package for senior citizen women is designed to evaluate key health parameters, address specific health concerns, and provide reassurance to both women and their families.
Importance of Regular Health Check-Ups
As women grow older, the body’s natural ability to repair and recover slows down. This increases the chances of developing conditions such as diabetes, hypertension, osteoporosis, thyroid disorders, and cardiovascular diseases. In addition, post-menopausal women are more prone to hormonal imbalances, bone density loss, and metabolic changes. A well-structured diagnostic package offers a detailed assessment of these risk factors, enabling early intervention and management. Preventive healthcare not only helps in prolonging life but also ensures that the golden years are lived with vitality and independence.
Key Inclusions in the Diagnostic Package
A comprehensive diagnostic package for senior citizen women usually includes a wide range of tests to assess overall health. Some of the common components are:
- Blood Tests: These include complete blood count (CBC), blood sugar levels (fasting and postprandial), HbA1c, and lipid profile. They provide crucial insights into diabetes, cholesterol levels, and general health status.
- Kidney and Liver Function Tests: These tests check for abnormalities in kidney and liver performance, which can be affected with age and long-term medication use.
- Thyroid Profile: Thyroid imbalances are common among elderly women and can affect metabolism, mood, and energy levels.
- Bone Health Assessment: Tests like Vitamin D, Vitamin B12 and Calcium helps in identifying osteoporosis and reducing the risk of fractures.
- Cancer Screening: Specific screenings such as CA-125 and PSA are essential for detecting breast and cervical cancers at an early stage.
- Urine Analysis: This test helps identify urinary tract infections, kidney disorders, or diabetes-related complications.
Benefits of the Package
The greatest advantage of a complete diagnostic package is early detection. Many illnesses remain silent in the initial stages and only manifest with severe complications. For example, osteoporosis may go unnoticed until a fracture occurs, or diabetes may remain undiagnosed until organ damage begins. By undergoing a regular health package, senior citizen women can safeguard themselves against such risks.
Moreover, these packages promote preventive healthcare rather than reactive treatments. With early diagnosis, lifestyle changes, medications, and therapies can be introduced to slow disease progression. This helps in reducing healthcare expenses, avoiding hospital admissions, and enhancing mental peace.
A Step towards Healthy Aging
Health is the foundation of a fulfilling life. Senior citizen women deserve the best medical attention to ensure they remain active, energetic, and self-reliant. A complete diagnostic package is not just a medical routine; it is a thoughtful investment in longevity, independence, and happiness. By prioritizing regular health assessments, families can ensure that their loved ones embrace aging gracefully, with confidence and good health.
At Manipal TRUtest, we offer specialized diagnostic packages designed for senior women’s health needs, combining advanced testing with compassionate care. Book a package today and take a proactive step toward healthier aging.

Womens Health
Women with Early Period Cessation Face Higher Autoimmune Disease Risks
Recent research reveals that women experiencing premature ovarian insufficiency (POI), a condition characterized by the cessation of menstruation before the age of 40, are significantly more susceptible to severe autoimmune diseases. This alarming finding underscores the critical need for awareness and further study into the health implications of POI.
POI affects approximately 1% of women globally, resulting from the ovaries ceasing to function properly, leading to irregular periods and symptoms akin to menopause. A comprehensive study published in a prominent medical journal has shown that women diagnosed with POI are two to three times more likely to develop serious autoimmune conditions such as type 1 diabetes, lupus, overactive thyroid, and inflammatory bowel disease compared to their peers without POI.
The investigation, conducted by Finnish researchers, tracked nearly 20,000 women over a span of 12 years. The researchers meticulously analyzed health data from Finland's extensive health registries, focusing on nearly 4,000 women diagnosed with POI between 1988 and 2017. Each of these women was paired with four control subjects of similar age, allowing the team to draw meaningful comparisons regarding the onset of autoimmune diseases between the two groups.
Findings indicated that 5.6% of women with POI had an autoimmune disorder prior to their POI diagnosis, while 12.7% were diagnosed with one afterward. The study found that women with POI were 2.6 times more likely to have an autoimmune disease before their diagnosis compared to the control group, with risks varying for specific conditions. Notably, the likelihood of developing polyglandular autoimmune diseases was nearly 26 times higher.
Importantly, the researchers cautioned that these figures may be conservative, as the study focused only on severe autoimmune disorders diagnosed in specialized health centers. Common conditions like coeliac disease and underactive thyroid, often treated in primary care, might not have been fully accounted for, suggesting an even higher prevalence of autoimmune disorders in women with POI.
The doctor who led the study emphasized that while many women with POI do not go on to develop severe autoimmune conditions, healthcare providers should recognize the increased risk. This awareness is vital, as POI can jeopardize fertility, prompting early family planning considerations.
Looking ahead, researchers are keen to explore the biological mechanisms linking POI and autoimmune diseases, with the aim of developing preventive treatments. This ongoing investigation will include assessing the potential benefits of hormone replacement therapy for women with POI, which may mitigate the onset of other health complications.
Experts are advocating for more research into POI, particularly regarding its complex relationship with autoimmune diseases. The call for a multidisciplinary approach in treating women with POI emphasizes the importance of holistic healthcare that addresses the long-term health risks associated with this condition.
It's advisable for women to schedule routine health check-ups to identify and address any potential complications early on.